Ionis Pharmaceuticals IONS Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's operating cash flow?
- Ionis Pharmaceuticals (IONS) reported operating cash flow of -$792.82M in Q1 2026.
- How has Ionis Pharmaceuticals's operating cash flow changed year-over-year?
- Ionis Pharmaceuticals's operating cash flow decreased by 425.8% year-over-year, from -$150.78M to -$792.82M.
- What is the long-term trend for Ionis Pharmaceuticals's operating cash flow?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's operating cash flow has grown at a 71.8% compound annual growth rate (CAGR), from $30.8M to -$268.58M.
- What does operating cash flow mean?
- The cash generated from the company's day-to-day business operations.
- How do you interpret operating cash flow?
- Positive values indicate the business can fund operations internally, while negative values suggest a reliance on external financing or cash reserves.
- How does operating cash flow compare across companies?
- Standard measure of operational health across all industries.